← Eichor
Condition: Healthy Male And Female Subjects Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Healthy Male And Female Subjects

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Validation Study of an Assistive Pulse Data Collection Device
Phase 1 · 1 location(s) · The Hong Kong Polytechnic University · NCT06974227Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
NA · 1 location(s) · Scott Silveira · NCT07144527To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
Phase 1 · 1 location(s) · Prestige Biopharma Limited · NCT05108259A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Phase 1/Phase 2 · 7 location(s) · Rhythm Pharmaceuticals, Inc. · NCT06239116A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insuffici
Phase 1 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07001436Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)
NA · 1 location(s) · The Methodist Hospital Research Institute · NCT06664827To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects
Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT07013773Effects of Recreational Soccer Training on Physical Fitness and Gross Motor Coordination in Prepubertal Boys and Girls
NA · 1 location(s) · Riphah International University · NCT06867679A Study of JPH034 in Healthy Adult Participants
Phase 1 · 1 location(s) · J-Pharma Co., Ltd. · NCT07534657Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepati
Phase 1 · 2 location(s) · Atea Pharmaceuticals, Inc. · NCT06911320Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject
Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT06935721A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People
Phase 1 · 1 location(s) · Boehringer Ingelheim · NCT07486115Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerab
Phase 1 · 1 location(s) · Gliknik Inc. · NCT05318534A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
Phase 1 · 1 location(s) · Hansoh BioMedical R&D Company · NCT05942625A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus
Phase 1 · 1 location(s) · Ono Pharmaceutical Co., Ltd. · NCT07619157A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women
Phase 1 · 1 location(s) · Boehringer Ingelheim · NCT06916702Near-InfraRed Spectroscopy of Auricular Stimulation
NA · 1 location(s) · University of Pittsburgh · NCT06825364Urinary Vitamin C Loss in Diabetic Subjects
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00071526Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects
Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT06935682
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.